Clinical Trials Logo

Clinical Trial Summary

A single-center prospective study. Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Minimally Invasive Cardiac Surgery

NCT number NCT05462769
Study type Observational
Source Karolinska University Hospital
Contact Magnus Dalén
Phone +46 (0) 8 123 700 00
Email magnus.dalen@karolinska.se
Status Recruiting
Phase
Start date August 1, 2017
Completion date December 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05104320 - The Quality of Life and Patency Rate After Minimally Invasive Cardiac Surgery N/A
Completed NCT05527756 - Evaluation of the Cosmetic Outcomes of Totally Endoscopic Cardiac Surgery
Not yet recruiting NCT03505242 - Application of Bronchial Blocker in Minimally Invasive Cardiac Surgery N/A
Completed NCT05038111 - Medical Records Investigation of Whether Perioperative Dexmedetomidine Will Reduce the Duration of Mechanical Ventilation or Hospital Length of Stay in Patients Undergoing Minimally Invasive Cardiac Surgery